HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

Skye Bioscience, Inc.

Contributing Author

Recent Articles by Skye Bioscience, Inc.

May-22
Skye Bioscience to Participate in Upcoming Investment Conferences SKYE GlobeNewswire
May-19
Skye Bioscience Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab SKYE GlobeNewswire
May-13
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) SKYE GlobeNewswire
May-13
Skye Bioscience Clinical Model Demonstrating Necessity of Peripheral CB1 Inhibition for Weight Loss Presented at European Congress on Obesity SKYE GlobeNewswire
May-08
Skye Bioscience Reports First Quarter 2025 Results and Highlights Nimacimab Differentiation in Obesity SKYE GlobeNewswire
May-07
Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025 SKYE GlobeNewswire
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite